Novel Procedure May Eliminate Insulin Dependency in Type 2 …
Oct 15, 2024 · PIONEERING research presented at the United European Gastroenterology (UEG) Week 2024 has revealed a new treatment approach for Type 2 diabetes (T2D) that could dramatically reduce, or even eliminate, the need for insulin therapy.. Over 422 million people globally live with T2D, with most patients relying on insulin therapy to …
- [PDF]
Abstract Highlights
The following highlights showcase late-breaking research presented at the European Academy of Dermatology and Venereology (EADV) Congress 2024.
May 2, 2024 · Abbreviations: AML: acute myeloid leukemia; CCUS: clonal cytopenia of undetermined significance; del: deletion; EB: excess blasts; FISH: fluorescence in situ ...
CC B Ó-NC . Licence É Copyright 22 EMJ É August 22 É Neurology 51 Meeting Summary Nipocalimab, a high-affinity, fully human, aglycosylated, effectorless ...
- [PDF]
Abstract Highlights
The following abstract highlights spotlight selected abstracts presented at the European Respiratory Society (ERS) Congress 2024. They cover key topics, including lung cancer screening
The Advances in Treatment Options for Conditions Causing Hair Loss
Nov 7, 2024 · DRUGS. Oral and topical JAK inhibitors have emerged as promising treatments for autoimmune-related hair loss, particularly alopecia areata. 3 JAK inhibitors function through inhibition of enzymes in the JAK/signal transducer and activator of transcription (STAT) signalling pathway, regulating immune system activity. Currently, three JAK inhibitors have been approved by the FDA for the ...
ACG Updates Guidelines for Management of Helicobacter Pylori
Oct 31, 2024 · The AMERICAN College of Gastroenterology (ACG) has issued a new clinical guideline to help healthcare providers more effectively manage Helicobacter pylori, a widespread bacterial infection associated with conditions ranging from dyspepsia and peptic ulcers to gastric cancer.. This new guideline, aimed at enhancing treatment outcomes for patients in North America, is based on a systematic ...
Why EGFR Exon 21 L858R Mutations Should Be Treated Differently
BACKGROUND. EGFR gene mutations have been reported in 15–60% of non-small cell lung cancers (NSCLCs) with an important difference in prevalence between Eastern and Western populations. 1,2 The most common EGFR-activating mutations in NSCLC include in-frame deletions in exon 19 and a substitution in exon 21 (L858R) which account for 47% and 41%, respectively, of observed EGFR mutations in ...
EMJ | Elevating the quality of healthcare globally
In this episode, Jonathan Sackier sits down with David Wan to discuss the latest advances in colorectal cancer screening, the importance of high-quality colonoscopy, and the emerging role of AI in polyp detection.
30 EM Ø September 2024 Ø Copyright 2024 EM Ø CC BY-NC 4.0 Licence Clinical Practice Insights for Hyperpigmentation Treatment Interview Summary Hyperpigmentation ...